CD99 Identifies Disease Stem Cells in Acute Myeloid Leukemia (AML) and the Myelodysplastic Syndromes (MDS)

被引：0
|
作者：
Chung, Stephen S. [1 ]
Devlin, Sean [1 ]
Park, Christopher Y. [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2014年 / 14卷
关键词：
D O I：
10.1016/j.clml.2014.06.041
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
208
引用
收藏
页码：S121 / S121
页数：1
相关论文
共 50 条
  • [1] CD99 IDENTIFIES DISEASE STEM CELLS IN ACUTE MYELOID LEUKEMIA (AML) AND THE MYELODYSPLASTIC SYNDROMES (MDS)
    Chung, Stephen
    Pang, Wendy
    Jan, Max
    Klimek, Virginia
    Weissman, Irving
    Majeti, Ravindra
    Park, Christopher
    EXPERIMENTAL HEMATOLOGY, 2013, 41 (08) : S16 - S16
  • [2] CD99 Identifies Disease Stem Cells in Acute Myeloid Leukemia and the Myelodysplastic Syndromes
    Chung, Stephen S.
    Pang, Wendy W.
    In, Gino K.
    Jan, Max
    Klimek, Virginia M.
    Melnick, Ari
    Weissman, Irving L.
    Majeti, Ravi
    Park, Christopher Y.
    BLOOD, 2012, 120 (21)
  • [3] CD99 Is a Therapeutic Target On Disease Stem Cells In Acute Myeloid Leukemia and The Myelodysplastic Syndromes
    Chung, Stephen S.
    Tavakkoli, Montreh
    Devlin, Sean M.
    Park, Christopher Y.
    BLOOD, 2013, 122 (21)
  • [4] CD99 IS A THERAPEUTIC TARGET ON DISEASE STEM CELLS IN ACUTE MYELOID LEUKEMIA AND THE MYELODYSPLASTIC SYNDROMES
    Chung, Stephen
    Klimek, Virginia
    Park, Christopher
    EXPERIMENTAL HEMATOLOGY, 2014, 42 (08) : S20 - S20
  • [5] CD99 Is a Therapeutic Target on Disease Initiating Stem Cells in Acute Myeloid Leukemia and the Myelodysplastic Syndromes
    Chung, Stephen S.
    Tavakkoli, Montreh
    Klimek, Virginia M.
    Park, Christopher Y.
    BLOOD, 2014, 124 (21)
  • [6] CONNECT MDS AND AML: THE MYELODYSPLASTIC SYNDROMES (MDS) AND ACUTE MYELOID LEUKEMIA (AML) DISEASE REGISTRY
    Steensma, D.
    Abedi, M.
    Bejar, R.
    Cogle, C.
    Foucar, K.
    Garcia-Manero, G.
    George, T.
    Grinblatt, D.
    Komrokji, R.
    Maciejewski, J.
    Pollyea, D.
    Roboz, G.
    Savona, M.
    Scott, B.
    Sekeres, M.
    Thompson, M.
    Sugrue, M.
    Swern, A.
    Nifenecker, M.
    Erba, H.
    LEUKEMIA RESEARCH, 2015, 39 : S124 - S124
  • [7] Diagnostic of myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML)
    Germing, Ulrich
    Haferlach, Torsten
    LABORATORIUMSMEDIZIN-JOURNAL OF LABORATORY MEDICINE, 2015, 39 (05): : 291 - 299
  • [8] CD99 Is a Diagnostic and Therapeutic Target on Disease Stem Cells in MDS and AML
    Chung, S. S.
    Pang, W. W.
    Devlin, S.
    Klimek, V. M.
    Melnick, A.
    Park, C. Y.
    MODERN PATHOLOGY, 2014, 27 : 343A - 343A
  • [9] CD99 Is a Diagnostic and Therapeutic Target on Disease Stem Cells in MDS and AML
    Chung, S. S.
    Pang, W. W.
    Devlin, S.
    Klimek, V. M.
    Melnick, A.
    Park, C. Y.
    LABORATORY INVESTIGATION, 2014, 94 : 343A - 343A
  • [10] Do preclinical studies suggest that CD99 is a potential therapeutic target in acute myeloid leukemia and the myelodysplastic syndromes?
    Tavakkoli, Montreh
    Chung, Stephen S.
    Park, Christopher Y.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2018, 22 (05) : 381 - 383
12345